In ER(+) T47D-BAF cells co-cultured with breast adipose fibroblasts, resveratrol showed an aromatase inhibitory effect with a potency comparable to letrozole, which is a clinically used anti-aromatase drug in breast cancer treatment [79]. This evidence concerns the gene CYP19A1 and breast carcinoma.